Search results
Regeneron is a biotech company that develops new medicines for serious diseases using novel technologies and scientific innovation. Learn about its history, research areas, clinical trials, responsibility goals, STEM programs and more.
- Career Opportunities
Working at Regeneron We are a team of original thinkers who...
- Approved Medicines
Regeneron (NASDAQ: REGN) is a leading biotechnology company...
- Locations & Contact
An important note about privacy: Regeneron is committed to...
- Investigational Pipeline
UPDATE: Due to the high circulation of the SARS-CoV-2...
- Leadership
Leonard (Len) Brooks joined Regeneron in 2013 and serves as...
- About
Reinventing Drug Discovery. For 35 years, our mission has...
- Investor Relations
We are a leading science and technology company that...
- Medical Professionals
Regeneron’s Compassionate Use Policy gives certain patients...
- Collaborations
In an example of a commercial-stage agreement, Regeneron...
- Career Opportunities
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase ...
- 1988; 35 years ago
- Tarrytown, New York, U.S.
- 11,851 (December 2022)
- US$12.17 billion (2022)
Regeneron is a leading biotechnology company that seeks to invent, develop and commercialize life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, Regeneron has nine FDA- or EMA-approved treatments and numerous product candidates in development across multiple therapeutic areas, using novel and patented technologies such as VelocImmune® and Trap.
Regeneron Pharmaceuticals is a biopharmaceutical company that develops and produces FDA-approved medicines for various serious diseases. Learn about their pipeline of over 30 investigational medicines, their operations, their clinical trials and their patient safety.
People also ask
Where is Regeneron Pharmaceuticals headquartered?
What does Regeneron do?
Is Regeneron a free drug?
Who invented Regeneron?
Learn how Regeneron has used the power of science to bring new medicines to patients since 1988. Explore the milestones, achievements and challenges of the biotechnology company over four decades.
Regeneron applied its scientific and technology expertise to combat COVID-19 with a novel antibody combination therapy that received emergency use authorization in 2020 and blocked the SARS-CoV-2 virus. Learn how Regeneron applied its VelociSuite® technologies, evaluated hundreds of antibodies, and explored new potential medicines for other infectious diseases.
